On 9 November 2021, the board of directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. received resignation letters from Mr. Gong Ping and Mr. Zhang Houlin both are non- executive Directors: Mr. Gong resigned as a non-executive Director due to work arrangement, and ceased to be a member of the audit committee of the Board and Mr. Zhang has resigned as a non-executive Director due to work arrangement. In accordance with the articles of association of the Company, the resignation of Mr. Gong and Mr. Zhang shall become effective from 9 November 2021. The Board announce the proposed appointments of Mr. Wang Kexin and Ms. Guan Xiaohui as executive Directors of the eighth session of the Board. The proposed appointments of Mr. Wang and Ms. Guan are subject to the approval of the Shareholders at the general meeting. Given Mr. Gong resigned as a non-executive Director and ceased to be a member of the Audit Committee with effect from 9 November 2021, the Board announces that Ms. Li Ling has been appointed as a member of the Audit Committee with effect from 9 November 2021.